TPP1 and glycogen storage disease VI: Recombinant TPP1 (cerliponase alfa) was approved for treatment of the brain in CLN2 disease, an inherited lysosomal storage disorder, and the enzyme was infused into one lateral ventricle bimonthly via an Ommaya reservoir [110].